Preclinical studies: Initial testing in laboratories and on animals to identify any potential toxicity. Phase I trials: Small-scale trials on healthy volunteers to assess the safety and dosage. Phase II and III trials: Larger trials on patient populations to further evaluate safety and efficacy. Post-marketing surveillance: Ongoing monitoring of the intervention in the general population to detect any long-term or rare adverse effects.
